Co-diagnostics Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CODX Co-diagnostics Inc.

Closed Mourning Day 01-08 16:00:00 EST

0.7754

-0.0883

-10.22%

盘后0.7814

+0.0060+0.77%

19:49 EST

High0.8990	Low0.7521	Vol274.50K
Open0.8800	D1 Closing0.8637	Amplitude17.01%
Mkt Cap24.76M	Tradable Cap23.04M	Total Shares31.93M
T/O220.45K	T/O Rate0.92%	Tradable Shares29.71M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CODX","market":"US","secType":"STK","nameCN":"Co-diagnostics Inc.","latestPrice":0.7754,"timestamp":1736370000000,"preClose":0.8637,"halted":0,"volume":274503,"hourTrading":{"tag":"盘后","latestPrice":0.7814,"preClose":0.7754,"latestTime":"19:49 EST","volume":6778,"amount":5294.397701,"timestamp":1736383785314},"delay":0,"floatShares":29713926,"shares":31929752,"eps":-1.37692,"marketStatus":"Closed Mourning Day","change":-0.0883,"latestTime":"01-08 16:00:00 EST","open":0.88,"high":0.899,"low":0.7521,"amount":220446.92769471,"amplitude":0.170082,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.37692,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1736499600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.8637,"preHourTrading":{"tag":"盘前","latestPrice":0.8723,"preClose":0.8637,"latestTime":"09:10 EST","volume":816,"amount":705.9673776,"timestamp":1736345441281},"postHourTrading":{"tag":"盘后","latestPrice":0.7814,"preClose":0.7754,"latestTime":"19:49 EST","volume":6778,"amount":5294.397701,"timestamp":1736383785314},"volumeRatio":0.35846476896479385,"impliedVol":3.563,"impliedVolPercentile":0.9762},"requestUrl":"/m/hq/s/CODX/tweets","defaultTab":"tweets","newsList":[{"id":"2501989786","title":"Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501989786","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501989786?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:30","pubTimestamp":1736260200,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Jan. 7, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be participating in Nasdaq's Live from MarketSite broadcast at the Silicon Slopes Summit 2025 on January 14, 2025.The Company's existing Co-Dx Logix Smart ABC  Test already detects all known circulating strains of H5N1 and is available for purchase by qualified centralized laboratories as a Research Use Only ** assay within the United States, and as an in vitro diagnostic  in regions that accept CE markings as valid regulatory clearance. Co-Diagnostics has also completed the principal design work and in silico analysis of an H5N1-specific target, which could be used as a standalone test or even added to the existing ABC test as needed.About Co-Diagnostics, Inc.:Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-participate-nasdaq-143000794.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-participate-nasdaq-143000794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","BK4585","LU2210149790.SGD","BK4588","BK4139","BK4551","BK4082","BK4535","LU2095319765.USD","IE00BKPKM429.USD","NDAQ","BK4568","BK4548","IE00B64PRP62.GBP","BNTX","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4112","CODX","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2490936010","title":"Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2490936010","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490936010?lang=en_us&edition=fundamental","pubTime":"2024-12-10 22:30","pubTimestamp":1733841000,"startTime":"0","endTime":"0","summary":"New oligonucleotide facility is designed to support \"Make in India\" initiative by synthesizing Co-Primers in-house. Attendees of new ribbon-cutting event expected to include representatives from NGOs and government leaders. SALT LAKE CITY, Dec. 10, 2024 /PRNewswire/ --Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the inauguration of CoSara Diagnostics Pvt. Ltd.'soligonucleotide synthesis facility will take place December 11, 2024, in Ranoli, India.In support of the \"Make in India\" initiative, the new facility is designed to manufacture the Company's patented Co-Primers chemistry, which underpins Co-Dx's and CoSara's lab-based PCR diagnostic tests and which powers the test cups for the new Co-Dx PCR at-home and point-of-care testing platform*. Qualifying under this initiative is anticipated to facilitate access to India's large and robust healthcare marketplace.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-cosara-diagnostics-143000245.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-cosara-diagnostics-143000245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2485787982","title":"WHO extends mpox emergency; Canada reports first clade I case","url":"https://stock-news.laohu8.com/highlight/detail?id=2485787982","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485787982?lang=en_us&edition=fundamental","pubTime":"2024-11-24 03:48","pubTimestamp":1732391286,"startTime":"0","endTime":"0","summary":"JUN LICanada has reported the first mpox case linked to the Clade I variant of the virus, which is driving the ongoing mpox outbreak in Africa. Meanwhile, the World Health Organization said it continu","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166765861/image_2166765861.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166765861/image_2166765861.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4325199-who-extends-mpox-emergency-canada-reports-first-clade-i-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["SG9999004303.SGD","BK4566","SG9999002224.SGD","BK4568","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0868494617.USD","IE00B2B36J28.USD","LU0266013472.USD","LU1057294990.SGD","LU2237957902.USD","BK4139","LU1721429741.USD","LU1061106388.HKD","LU1989763427.SGD","LU1691799644.USD","LU1721429402.USD","IE00BJJMRZ35.SGD","BK4588","LU0122379950.USD","LU2468319806.SGD","ABT","BK4504","BK4585","BK4533","LU1914381329.SGD","LU0170899867.USD","LU2089984988.USD","BVNKF","LU0234572021.USD","IE0002141913.USD","SGXZ23171101.USD","BK4581","BK4592","LU2237957811.SGD","BVNRY","LU1989763690.USD","SG9999002232.USD","IE0009355771.USD","CODX","LU1023059063.AUD","BK4082","LU2112291526.USD"],"gpt_icon":0},{"id":"2482563200","title":"Co-Diagnostics Price Target Maintained With a $1.50/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2482563200","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482563200?lang=en_us&edition=fundamental","pubTime":"2024-11-11 19:55","pubTimestamp":1731326100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CODX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 11, 2024 06:55 ET (11:55 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX"],"gpt_icon":0},{"id":"2482263105","title":"Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2482263105","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482263105?lang=en_us&edition=fundamental","pubTime":"2024-11-10 20:30","pubTimestamp":1731241816,"startTime":"0","endTime":"0","summary":"NasdaqCM:CODX Earnings and Revenue Growth November 10th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 71%. Earnings per share  also surpassed analyst estimates by 3.0%.Looking ahead, revenue is expected to decline by 95% p.a. on average during the next 2 years, while revenues in the Medical Equipment industry in the US are expected to grow by 8.3%.The company's shares are down 5.8% from a week ago.We don't want to rain on the parade too much, but we did also find 5 warning signs for Co-Diagnostics (1 makes us a bit uncomfortable!) that you need to be mindful of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-third-quarter-2024-123016218.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX"],"gpt_icon":0},{"id":"2481100539","title":"Co-Diagnostics Inc (CODX) Q3 2024 Earnings Call Highlights: Navigating Revenue Decline and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2481100539","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481100539?lang=en_us&edition=fundamental","pubTime":"2024-11-08 23:03","pubTimestamp":1731078191,"startTime":"0","endTime":"0","summary":"Total Revenue: $0.6 million, down from $2.5 million in the prior year same period.Grant Revenue: $0.4 million in the third quarter of 2024.Product Revenue: $0.2 million in the third quarter of 2024.Gross Profit: $0.3 million, compared to $2.2 million in the prior year comparable period.Total Operating Expenses: $10.6 million, decreased from $11.1 million in the third quarter of 2023.Research and Development Expenses: $4.9 million, compared to $5.8 million in the prior year period.Income Before Taxes: Loss of $9.7 million, compared to a loss of $8.1 million in the prior year.Net Loss: $9.7 million or $0.32 per fully diluted share, compared to a net loss of $6.0 million or $0.20 per fully diluted share in the prior year.Adjusted EBITDA: Loss of $8.8 million, compared to a loss of $6.5 million in the prior year.Cash, Cash Equivalents, and Marketable Investment Securities: $37.7 million at the end of the quarter.GuruFocus has detected 5 Warning Signs with CODX.Co-Diagnostics Inc  has made ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gY1zAyP_yM8I1zhtICTwBw--~B/aD0yNDM7dz0yNDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ba002a6338b45ced3986505d6cb81cff","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gY1zAyP_yM8I1zhtICTwBw--~B/aD0yNDM7dz0yNDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ba002a6338b45ced3986505d6cb81cff"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-codx-q3-150311032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX"],"gpt_icon":0},{"id":"2481190660","title":"Co-Diagnostics Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2481190660","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481190660?lang=en_us&edition=fundamental","pubTime":"2024-11-08 12:58","pubTimestamp":1731041939,"startTime":"0","endTime":"0","summary":"* Co-Diagnostics Inc    reported a quarterly adjusted loss of 32 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -20 cents. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX"],"gpt_icon":0},{"id":"2481500941","title":"Co-Diagnostics Q3 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $641.141K Beat $375.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481500941","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481500941?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:59","pubTimestamp":1731016795,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.33) by 3.03 percent. This is a 60 percent decrease over losses of $(0.20) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41826969/co-diagnostics-q3-2024-gaap-eps-0-32-beats-0-33-estimate-sales-641-141k-beat-375-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Co-Diagnostics Q3 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $641.141K Beat $375.000K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX"],"gpt_icon":0},{"id":"2481151522","title":"Co-Diagnostics Q3 Revenue USD 600 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2481151522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481151522?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:01","pubTimestamp":1731013268,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nPLX690139:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2481193552","title":"Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481193552","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481193552?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:01","pubTimestamp":1731013260,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ --Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended September 30, 2024.Revenue of $0.6 million, which declined from $2.5 million during the prior year primarily due to timing of grant revenue recognition. Grant revenue totaled $0.4 million while product revenue totaled $0.2 million. Operating expenses of $10.6 million decreased by 5.0% from the prior year due to higher expenses in 2023 related to platform development and regulatory submission preparation. Net loss of $9.7 million, compared to net loss of $6.0 million in the prior year, representing a loss of $0.32 per fully diluted share, compared to a loss of $0.20 per fully diluted share in the prior year. \"Co-Diagnostics has made significant progress on our tests, and look forward to providing you with regulatory and commercialization updates as they","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-reports-third-210100037.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-reports-third-210100037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX","BK4082","BK4568"],"gpt_icon":0},{"id":"2481168813","title":"Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481168813","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481168813?lang=en_us&edition=fundamental","pubTime":"2024-11-05 22:30","pubTimestamp":1730817000,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Nov. 5, 2024 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth and delivering a presentation at the MEDICA 2024 trade fair in Düsseldorf, Germany on November 11-14.MEDICA has become the largest medical B2B trade fair in the world, attracting 83,000 visitors and over 5,300 exhibitors from almost 70 countries. The Company expects to use the opportunity to generate increased interest in its suite of PCR in vitro diagnostic and research products for infectious diseases, and to introduce and promote its Co-Primers technology and applications to a wide audience of international attendees.About Co-Diagnostics, Inc.:Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-143000990.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-143000990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4218","BK4568","BK4181","BK4588","CODX","HST","BK4082"],"gpt_icon":0},{"id":"2479081750","title":"Is Co-Diagnostics (NASDAQ:CODX) In A Good Position To Deliver On Growth Plans?","url":"https://stock-news.laohu8.com/highlight/detail?id=2479081750","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479081750?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:45","pubTimestamp":1730378730,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.So should Co-Diagnostics  shareholders be worried about its cash burn?In this article, we define cash burn as its annual  free cash flow, which is the amount of money a company spends each year to fund its growth. First, we'll determine its cash runway by comparing its cash burn with its cash reserves.Since it has a market capitalisation of US$39m, Co-Diagnostics' US$25m in cash burn equates to about 66% of","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-nasdaq-codx-good-124530870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NDAQ","TQQQ","LU2210149790.SGD","IE00B64PRP62.GBP","LU2095319765.USD","BK4585","IE00BKPKM429.USD","MNQmain","BK4568","IE00BGHQF748.EUR","NQmain","LU2210150020.SGD","QID","BK4082","CODX","IE00B3QW5Z07.USD","PSQ","BK4112","BK4588","QLD",".IXIC","SQQQ"],"gpt_icon":1},{"id":"2478694959","title":"Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2478694959","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478694959?lang=en_us&edition=fundamental","pubTime":"2024-10-26 04:01","pubTimestamp":1729886460,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Oct. 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2024 results on Thursday, November 7, 2024, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.The conference call and webcast will be available via:. If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.About Co-Diagnostics, Inc.Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-announces-third-200100624.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-announces-third-200100624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX"],"gpt_icon":0},{"id":"2477863672","title":"Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2477863672","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477863672?lang=en_us&edition=fundamental","pubTime":"2024-10-21 21:30","pubTimestamp":1729517400,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Oct. 21, 2024 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be hosting a booth at Africa Health/Medlab Africa in Cape Town, South Africa on October 22-24, 2024.Co-Dx believes that the trade show will contribute valuable insight into markets that are anticipated to play an important role in the Company's future. In a report issued in September 2023, the WHO estimated that 2.5 million people contracted tuberculosis  in the African Region in 2021, while noting that a large gap also remains between estimated TB cases and those identified. Co-Dx has several infectious disease tests in varying stages of development on the Company's upcoming Co-Dx PCR at-home and point-of-care platform*, including a test for TB.Forward-Looking Statements:This press release contains forward-looking statementswithin the meaning of the Private Secu","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-133000181.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-133000181.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","BK4568","HST","BK4585","BK4082","BK4218","BK4588","CODX"],"gpt_icon":0},{"id":"2474263777","title":"Alignment HealthCare Partners With Intermountain Health in Nevada","url":"https://stock-news.laohu8.com/highlight/detail?id=2474263777","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474263777?lang=en_us&edition=fundamental","pubTime":"2024-10-10 22:10","pubTimestamp":1728569400,"startTime":"0","endTime":"0","summary":"Alignment HealthCare, Inc.’s ALHC leading Medicare Advantage plan, Alignment Health Plan, is expanding its healthcare services in Nevada through a new agreement with Intermountain Health. Beginning Jan. 1, 2025, the partnership will give Medicare members in Clark and Washoe counties access to over 65 clinic locations, including 35 award-winning senior primary care clinics. This collaboration promises to enhance the level of care available to Nevada’s growing senior population.Alignment HealthCare, known for its mission-driven approach to providing high-quality, affordable care for Medicare Advantage members, collaborates with trusted providers to deliver coordinated, personalized care. Intermountain Health, a nonprofit system with 33 hospitals and 385 clinics across six states, is recognized for its leadership in transforming healthcare through evidence-based practices and community health initiatives. This partnership aims to provide expanded healthcare services to Nevada's senior pop","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZcqDt7bCeBMLkGs_KJ1O8A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZcqDt7bCeBMLkGs_KJ1O8A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alignment-healthcare-partners-intermountain-health-141000515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","ICCM","CODX","BK4568","BK4154","HQY","ALHC","BK4539","LU1169589451.USD","LU2065731478.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2474333785","title":"Co-Diagnostics Inc (CODX) Q2 2024 Earnings Call Highlights: Revenue Surge Amidst Regulatory Hurdles","url":"https://stock-news.laohu8.com/highlight/detail?id=2474333785","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474333785?lang=en_us&edition=fundamental","pubTime":"2024-10-10 05:58","pubTimestamp":1728511124,"startTime":"0","endTime":"0","summary":"Total Revenue: $2.7 million, up from $0.2 million in the prior year same period.Grant Revenue: $2.5 million in the second quarter of 2024.Product Revenue: $0.2 million in the second quarter of 2024.Gross Profit: $2.4 million, compared to negative $0.3 million in the prior year comparable period.Total Operating Expenses: Decreased to $10.1 million from $11.7 million in the second quarter of 2023.Research and Development Expenses: $5.6 million, down from $6.0 million in the prior year period.Income Before Taxes: Loss of $7.7 million, compared to a loss of $11.2 million in the prior year.Net Loss: $7.6 million or a loss of $0.25 per fully diluted share, compared to a net loss of $8.9 million or a loss of $0.31 per fully diluted share in the prior year.Cash Position: $44.9 million in cash, cash equivalents, and marketable investment securities.GuruFocus has detected 5 Warning Signs with CODX.Co-Diagnostics Inc  showcased their Co-Dx PCR platform at major trade shows, strengthening relation","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gY1zAyP_yM8I1zhtICTwBw--~B/aD0yNDM7dz0yNDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ba002a6338b45ced3986505d6cb81cff","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gY1zAyP_yM8I1zhtICTwBw--~B/aD0yNDM7dz0yNDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ba002a6338b45ced3986505d6cb81cff"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-codx-q2-215844126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX"],"gpt_icon":0},{"id":"2472434526","title":"Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3","url":"https://stock-news.laohu8.com/highlight/detail?id=2472434526","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472434526?lang=en_us&edition=fundamental","pubTime":"2024-10-02 21:30","pubTimestamp":1727875800,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Oct. 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be hosting a booth at the Utah Health Care Association/Utah Center for Assisted Living  Convention & Expo at the Mountain America Expo Center in Sandy, Utah on October 2-3, 2024.The UHCA/UCAL Convention includes sessions and events for executive leadership, administrators, corporate personnel, owners, and Directors of Nursing for skilled nursing, assisted living and intermediate care facilities, and will include an expo for companies to exhibit their products and services relevant to these industries. The Co-Dx booth will showcase the Company's upcoming Co-Dx PCR platform*, including the menu of at-home and point-of-care tests in development.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-133000562.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-133000562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BK4218","BK4568","BK4585","BK4181","CODX","HST","BK4588"],"gpt_icon":0},{"id":"2469491901","title":"Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2469491901","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469491901?lang=en_us&edition=fundamental","pubTime":"2024-09-24 21:30","pubTimestamp":1727184600,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ --Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah Governor Cox and the Governor's Office of Economic Opportunity, as part of the latest World Trade Center  Utah trade mission to South Korea and Japan from September 24-October 5.Co-Dx will join the delegation for life sciences and innovation, aiming to expand its international relationships. The company announced the creation of a joint venture in India in 2017 called CoSara Diagnostics Pvt. Ltd. and has also developed a robust portfolio of distributors, partners and customers in more than 50 countries during the pandemic years when Co-Diagnostics distributed millions of COVID-19 PCR tests globally. The WTC trade mission comes as Co-Dx is strengthening global relationships in preparation for introducing a new PCR diagnostic platform designe","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-accompany-utah-133000877.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-accompany-utah-133000877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX","BK4082","BK4568"],"gpt_icon":0},{"id":"2465627314","title":"Market Today: Bitcoin Slumps, Coinbase Faces Regulatory Pressure, and Tesla Shines","url":"https://stock-news.laohu8.com/highlight/detail?id=2465627314","media":"GuruFocus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465627314?lang=en_us&edition=fundamental","pubTime":"2024-09-07 05:11","pubTimestamp":1725657088,"startTime":"0","endTime":"0","summary":"Market Overview September started on a downbeat note for the stock market. The major indices all registered sizable declines during this holiday-shortened week. Broad selling activity led the S&P 500 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2518539/market-today-bitcoin-slumps-coinbase-faces-regulatory-pressure-and-tesla-shines","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["TSLL","BK4550","LU0943347566.SGD","LU0820561909.HKD","LU1839511570.USD","LU2756315318.SGD","SMCI","09439","SG9999015978.USD","BK4554","BK4099","83042","BK4534","09008","LU0097036916.USD","AVGO","CODX","LU0689472784.USD","BK4082","LU2249611893.SGD","03439","BK4121","LU2357305700.SGD","SBUX","LU1720051017.SGD","LU0466842654.USD","BK4511","LU1861558580.USD","LU2756315664.SGD","03008","03042","TSLA","BK4516","BK4533","LU1861559042.SGD","BK4535","LU1551013342.USD","LU0964807845.USD","BK4548","BK4555","LU2087621335.USD","09042","LU1551013425.SGD","COIN","BK4112","SG9999015986.USD","LU0820561818.USD","APDN","BK4583"],"gpt_icon":1},{"id":"2465621851","title":"Applied DNA stock jumps amid U.S. government mpox update","url":"https://stock-news.laohu8.com/highlight/detail?id=2465621851","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465621851?lang=en_us&edition=fundamental","pubTime":"2024-09-07 03:45","pubTimestamp":1725651948,"startTime":"0","endTime":"0","summary":"Applied DNA Sciences  shares rose 17% in afternoon trading Friday after U.S. officials said the government was stepping up surveillance of the mpox virus in response to an ongoing outbreak in Africa. Also rising were shares of fellow mpox test maker Co-Diagnostics , which edged up 2%.  Other makers of mpox detection products include Abbott  and Roche . Earlier Friday, U.S. officials said during a briefing that the government was expanding surveillance along with access to mpox testing and vaccines amid an ongoing outbreak of the disease overseas. It added that no new cases of a more easily transmissible strain of the virus have been confirmed in the U.S., according to Reuters. Mpox, which is related to smallpox, is also known as monkeypox.","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166741669/image_2166741669.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166741669/image_2166741669.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4147758-applied-dna-stock-jumps-amid-us-government-mpox-update","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["TQQQ","BK4581","BK4583","PSQ","BK4588","SG9999002224.SGD","BK4585","APDN","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU1989763427.SGD","SG9999004303.SGD","NQmain","BK4504","LU1057294990.SGD","LU2089984988.USD","IE0002141913.USD","BK4533","BK4139","LU1023059063.AUD","BK4109","ABT","IE0009355771.USD","IE00B2B36J28.USD","LU1914381329.SGD","BK4592","03165","LU0868494617.USD","SQQQ","IE00BJJMRZ35.SGD","LU1989763690.USD","LU0170899867.USD","BK4566","SG9999002232.USD","BK4121","QLD",".IXIC","MNQmain","LU0122379950.USD","LU0266013472.USD","SGXZ23171101.USD","IE00BJT1NW94.SGD","BK4082","RHHBY","CODX","LU1691799644.USD","DNA","BK4007","QID"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.codiagnostics.com","stockEarnings":[{"period":"1week","weight":0.0339},{"period":"1month","weight":-0.0914},{"period":"3month","weight":-0.3894},{"period":"6month","weight":-0.4256},{"period":"1year","weight":-0.4461},{"period":"ytd","weight":0.0339}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0251},{"period":"3month","weight":0.0232},{"period":"6month","weight":0.0527},{"period":"1year","weight":0.244},{"period":"ytd","weight":0.0058}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.386004},{"month":2,"riseRate":0.285714,"avgChangeRate":0.321589},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.14957},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.009915},{"month":5,"riseRate":0.428571,"avgChangeRate":0.092054},{"month":6,"riseRate":1,"avgChangeRate":0.108385},{"month":7,"riseRate":0.714286,"avgChangeRate":0.208538},{"month":8,"riseRate":0.375,"avgChangeRate":-0.109957},{"month":9,"riseRate":0.25,"avgChangeRate":-0.032163},{"month":10,"riseRate":0.25,"avgChangeRate":-0.046183},{"month":11,"riseRate":0.25,"avgChangeRate":-0.068873},{"month":12,"riseRate":0.25,"avgChangeRate":-0.153453}],"exchange":"NASDAQ","name":"Co-diagnostics Inc.","nameEN":"Co-diagnostics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Co-diagnostics Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Co-diagnostics Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Co-diagnostics Inc.,CODX,Co-diagnostics Inc.股票,Co-diagnostics Inc.股票老虎,Co-diagnostics Inc.股票老虎国际,Co-diagnostics Inc.行情,Co-diagnostics Inc.股票行情,Co-diagnostics Inc.股价,Co-diagnostics Inc.股市,Co-diagnostics Inc.股票价格,Co-diagnostics Inc.股票交易,Co-diagnostics Inc.股票购买,Co-diagnostics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Co-diagnostics Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Co-diagnostics Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction